Dr Michael Charles Darder, MD | |
2720 Shadow Rdg, Kamas, UT 84036-5031 | |
(732) 236-2339 | |
(973) 290-8370 |
Full Name | Dr Michael Charles Darder |
---|---|
Gender | Male |
Speciality | Obstetrics & Gynecology - Reproductive Endocrinology |
Location | 2720 Shadow Rdg, Kamas, Utah |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1255478624 | NPI | - | NPPES |
Mailing Address | Practice Location Address |
---|---|
Dr Michael Charles Darder, MD 2720 Shadow Rdg, Kamas, UT 84036-5031 Ph: (732) 236-2339 | Dr Michael Charles Darder, MD 2720 Shadow Rdg, Kamas, UT 84036-5031 Ph: (732) 236-2339 |
News Archive
University of Otago researchers have been key partners in a study which has found poor sanitation facilities appear to be a major source of Salmonella Typhi, the cause of typhoid fever, in Fiji.
Endemic cholera, a potentially fatal diarrheal disease found in the world's most impoverished countries, could be effectively controlled by orally vaccinating half of the affected populations once every two years for only pennies per dose, according to new findings by an international team of researchers led by Ira M. Longini Jr., Ph.D., a biostatistician in the Vaccine and Infectious Disease Institute at Fred Hutchinson Cancer Research Center in Seattle. Longini and colleagues will report their findings online Nov. 27 in PLoS Medicine.
A promising new treatment for deadly brain tumors taken orally with minimal side effects is being studied by neurological researchers at Rush University Medical Center, Chicago.
An institute in Vietnam is formulating a new HIV/AIDS prevention project that will include input from people living with the disease, the Vietnamese News Agency reports.
Medicare beneficiaries have the ability to switch prescription drug plans, or enroll in the program for the first time, between Nov. 15 and Dec. 31 (Zhang, Wall Street Journal, 9/29). According to CMS spokesperson Tony Salters, about 10% to 15% of Medicare beneficiaries will switch prescription drug plans during the enrollment period (Moos, Dallas Morning News, 9/29).
› Verified 4 days ago